Cardinal Health, Inc. – Consensus Indicates Potential -1.5% Downside

DirectorsTalk Interviews

Cardinal Health, Inc. with ticker code (CAH) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 80 and 56 and has a mean target at 69.54. With the stocks previous close at 70.63 this would indicate that there is a downside of -1.5%. The day 50 moving average is 62.01 while the 200 day moving average is 56.08. The market cap for the company is $19,046m. Visit the company website at: https://www.cardinalhealth.com

The potential market cap would be $18,752m based on the market concensus.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Share on:

Latest Company News

Top China Investment Trust 2025 – Latest Research & Analysis

A distinctive way to access China’s equity market through small and mid-cap leaders, FCSS blends active management with structural flexibility and long-term positioning.

Filtronic secures €7m aerospace contract for LEO Satellite Programme

Filtronic has signed a contract worth over €7 million with a leading European aerospace manufacturer to supply RF assemblies for a major Low Earth Orbit satellite constellation.

Frontier Developments delivers strong Jurassic World launch, confirms Planet Zoo sequel

Frontier Developments has reported stronger-than-expected sales for Jurassic World Evolution 3, which surpassed 500,000 units within two weeks of release. Frontier also confirmed that a sequel to Planet Zoo, its

Hercules Academy on course to train 2,000 trainees in 2025

Hercules has announced that its Hercules Academy is on track to train 2,000 students in 2025, nearly double its original projection.

Fitch affirms Avation ‘B’ Rating with stable outlook

Avation PLC announced that Fitch Ratings has affirmed its Long-Term Issuer Default Rating at ‘B’ with a Stable Outlook.

Managers Back UK Income Stocks as Market Narrowness Signals Late-Cycle Conditions

UK income stocks seen as attractive amid market volatility, with managers highlighting undervaluation and narrowing global asset market conditions.

    Search

    Search